May 24, 2013     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
SNBL and Osaka City University to Conduct Joint Research on Severe Brain Damage
 

Tokyo, Mar 30, 2004 (JCN) - Shin Nippon Biomedical Laboratories (SNBL) and Osaka City University announced on March 26 that the two parties will sign a three-year joint research agreement on April 1.

The 45 million yen project will allow enable to jointly conduct researches on severe cerebral dysfunctions.

By Aki Tsukioka Contributor

Copyright © 2013 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Shin Nippon Biomedical Laboratories, Ltd. News  
  ShinNippon Agrees Licensing Nasal Drug Delivery Technology to Tokai Pharmaceuticals  (Aug 4, 2006)
  Shin Nippon Biomedical Laboratories, Takeda Pharmaceutical Successfully Complete Joint Research on Cynomolgus Monkey  (June 26, 2006)
  Shin Nippon Biomedical Laboratories Obtains New Knowledge on Drug-metabolizing Enzyme Cytochrome P450  (May 9, 2006)
  Shin Nippon Biomedical Laboratories Subsidiaries, Tokai Pharmaceuticals to Collaborate in Nasal Drug Delivery Technology  (Nov 25, 2005)
  Shin Nippon Biomedical Laboratories Develops Intranasal Morphine Preparation  (Nov 4, 2004)
  SNBL to Convert Resort Facilities in Kagoshima into Industry-academia R&D Laboratory  (July 9, 2004)
  SNBL and Tranzyme Pharma to Co-develop New Animal Model Using Primates  (Apr 19, 2004)
  SNBL and Osaka City University to Conduct Joint Research on Severe Brain Damage  (Mar 30, 2004)



 Recent  Biotech News   
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)

More Biotech news...

 Recent  Biotech News   
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)

More Biotech news...

 Recent  Biotech News   
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)

More Biotech news...

 Recent  Biotech News   
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)

More Biotech news...
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)